Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v5-FR
Language French French
Date Updated 2021-01-14 2020-07-23
Drug Identification Number 02364883 02364883
Brand name TEVA-MYCOPHENOLATE TEVA-MYCOPHENOLATE
Common or Proper name MYCOPHENOLATE 250MG CAP MYCOPHENOLATE 250MG CAP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL
Strength(s) 250MG 250MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size UD 100 UD 100
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-08-04 2020-08-04
Actual start date
Estimated end date 2020-11-30 2020-09-30
Actual end date 2021-01-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments We will be able to cover 100% of our current demand until August.
Health Canada comments